Natasha Gloeck
Biographic Data
| ID | 9064192 |
|---|---|
| NAME | Natasha Gloeck |
| GIVEN NAMES | Natasha |
| FAMILY NAME | Gloeck |
| SIGNATURE | GLOECK N |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Effectiveness of the BNT162b2 vaccine in preventing morbidity and mortality associated with Covid-19 in children aged 5 to 11 years
A rapid systematic review, based on Cochrane rapid review methodology was conducted to assess the effectiveness of two 10μg doses of BNT162b2 vaccine in preventing morbidity and mortality associated with COVID-19 in children aged 5 to 11 years. We searched the Cochrane Library COVID-19 study register, the COVID-NMA living review database and the McMaster University Living Evidence Synthesis for pre-appraised trials and observational studies up to…
No prominent works on this page.
Effectiveness of the BNT162b2 vaccine in preventing morbidity and mortality associated with Covid-19 in children aged 5 to 11 years
A rapid systematic review, based on Cochrane rapid review methodology was conducted to assess the effectiveness of two 10μg doses of BNT162b2 vaccine in preventing morbidity and mortality associated with COVID-19 in children aged 5 to 11 years. We searched the Cochrane Library COVID-19 study register, the COVID-NMA living review database and the McMaster University Living Evidence Synthesis for pre-appraised trials and observational studies up to…